Gartner Secures $368K Federal Advisory Contract From HHS for Research Services

Gartner, Inc. (NYSE: IT) has secured a new contract from the U.S. Department of Health and Human Services (HHS), specifically for the National Center for Advancing Translational Sciences (NCATS). Awarded on September 30, 2026, the ceiling value of the firm fixed-price order is $368,277 under an existing Gartner Enterprise-Wide Blanket Purchase Agreement. The work is expected to continue through September 29, 2031, and will support federal access to Gartner’s subscription-based research and advisory services. This underscores sustained demand for Gartner’s offerings within the public sector, particularly in healthcare research and advisory domains.

This contract was formally issued on the same day—September 30, 2026—not merely announced later. The award’s recent timing and direct relevance to Gartner’s core business of providing technology and advisory insight make it a material development. While the amount is modest relative to Gartner’s overall revenue, ongoing federal partnerships support the company’s long-term subscription revenue stability.

As of September 29, 2026, Gartner’s share price stood at precisely $185.85, reflecting a 0.95% intraday change, as reported. While this contract alone is unlikely to significantly sway the stock, it contributes to the broader stability and recurring revenue outlook that investors monitor.

Looking ahead, market participants may watch for further federal or institutional engagements with Gartner, along with its next earnings release and updated guidance, to assess continued strength in its subscription and advisory services pipeline.